Bone conduction implants (BCIs) are advanced hearing solutions designed for individuals with conductive or mixed hearing loss, and for those unable to benefit from conventional hearing aids. BCIs offer a low-risk surgical solution that enhances hearing ability and sound quality. Used for decades in hearing rehabilitation, the first BCI was implanted in 1977 in Gothenburg, Sweden. Over 100,000 BCIs have since been implanted with various devices and external processors. A BCI includes an external processor that amplifies sound and an internal component that sends vibratory energy directly to the temporal bone, bypassing damaged air conduction pathways to stimulate the cochlea. BCIs are particularly beneficial for patients with chronic ear conditions, congenital malformations, and single-sided deafness, offering a safe and reliable rehabilitation option.